BioSpace News Archive

CVS Health Corporation will hold a conference call with analysts and investors on Tuesday, May 4, 2021, at 8:00 a.m. to discuss its financial results for the first quarter of 2021.

Axion BioSystems, a leading life science tools company focused on developing and commercializing label-free, bioelectronic assays used to study the function of live cells in vitro, announces the formation of a Scientific Advisory Board.

GenSight Biologics, a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, reported its cash position as of March 31, 2021, and provided an operational update.

A coalition of 60 top hospitals and health care institutions have joined forces in a nationwide campaign to encourage adults to get vaccinated against COVID-19.

Evotec SE announced that the Company has initiated the construction of its J.POD 2 EU biologics manufacturing facility at Evotec’s Campus Curie in Toulouse, France.

BioArctic AB’s partner Eisai announced the publication of an article, A Randomized, Double-Blind Phase 2b Proof of Concept Clinical Trial in Early Alzheimer’s Disease with Lecanemab, an Anti-Aβ Protofibril Antibody, in the peer-reviewed journal Alzheimer’s Research & Therapy.

Vicore Pharma Holding AB, a pharmaceutical company developing innovative medicines for severe lung disorders such as idiopathic pulmonary fibrosis, announced that it will host a key opinion leader webinar on C21, the company’s lead asset for the treatment of COVID-19, on Wednesday, April 28, 2021 at 14:00 CET.

XPhyto Therapeutics Corp. is pleased to announce the appointment of Mr. Wolfgang Probst as the Chief Operations Officer of XPhyto and the addition of Mr. Manfred Buchberger as the Head of Corporate Development at XP Diagnostics GmbH, a wholly owned German subsidiary of the Company.

Completing the technical data set for self-declaration of a CE mark for professional use in early May, followed immediately by commercial launch in Europe

Gold Standard Diagnostics announced it offers a new B. burgdorferi VlsE-OspC IgG/IgM recombinant ELISA Screen that can be used to improve workflow and conserve testing resources.